EDGAR Filing Documents for 0001104659-17-063738

Form 8-K - Current report:

SEC Accession No. 0001104659-17-063738

Filing Date

2017-10-25

Accepted

2017-10-25 16:15:07

Documents

Period of Report

2017-10-23

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-24440_18k.htm	8-K	22865
2	EX-99.1	a17-24440_1ex99d1.htm	EX-99.1	17119
3	GRAPHIC	g244401mmi001.jpg	GRAPHIC	7608
	Complete submission text file	0001104659-17-063738.txt		51859

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 171153227
SIC: 2834 Pharmaceutical Preparations